Quick Summary
Rakesh Bansal Ventures is a SEBI registered Research Analyst held by Dr. Rakesh Bansal, INH100008984, active in the Indian markets since 1998 with the current registration perpetual since December 2021. No single one of its six research plans breaches the ₹1,51,000 annual SEBI fee ceiling on its own. Subscribing to several of them together, which the product range is built to encourage, can push a client’s annual total well past the limit. Payment for several plans is handled through third party platforms including Exly and Smallcase rather than directly on the firm’s own site, and one third party bio describes Dr. Bansal as an Investment Advisor, a different registration category from the one he actually holds.
Rakesh Bansal Ventures operates under SEBI Research Analyst registration INH100008984, held by Dr. Rakesh Bansal, active in Indian markets since 1998 and registered with SEBI since December 2021.
Individually, none of the firm’s six research plans cost enough in a year to breach the SEBI fee ceiling.
The product range is built around six distinct market segments, and a client interested in more than one of them, which the marketing actively encourages, can end up paying considerably more across a year than any single plan’s price suggests.
This page works through the registration, the full six-plan pricing table and what combining plans does to the fee cap math, and a labelling inconsistency worth knowing about before you subscribe.
Rakesh Bansal Ventures Review
Dr. Rakesh Bansal has been active in Indian financial markets since 1998, and the firm’s own material states he has over 27 years of experience in market analysis and trading education.
His registered service is centred on technical analysis, structured trading strategies, and defined entry, exit, and stop-loss levels, covering index trading, options, futures, commodities, delivery-based stocks, and momentum-based portfolio strategies.
Six branded subscription products carry this research to clients: Index Ka Boss, Options Ka Ustaad, Delivery Dhamaka, Futures Ka Boss, Commodity Ka Sikandar, and Alpha360 Momentum Smallcase.
Beyond research subscriptions, Dr. Bansal runs paid trading education courses and has authored books covering short-term trading, Elliott Wave strategies, and Dow Theory.
He has appeared as a market commentator on Zee Business, CNBC Awaaz, ET Now and DD News, with a media presence particularly tied to Zee Business since 2018, and maintains an active following across YouTube, Instagram, Facebook, LinkedIn, X and a WhatsApp channel.
A mobile app delivers research alerts, market updates, community discussions, quizzes, polls and live events to subscribers.
That app’s own user ratings are covered in full on our Rakesh Bansal Ventures Reviews page, since they tell a different story from the firm’s public media profile.
None of this establishes wrongdoing, and nothing further on this page does either. Where a registered analyst’s conduct does cross a line, the formal escalation route is covered below.
Is Rakesh Bansal Ventures SEBI Registered?
Yes, and the registration is confirmed consistently across the firm’s own site, its Telegram channel, and third-party listings that independently cite the same number.
| Detail | Information |
|---|---|
| Name | Rakesh Bansal Ventures |
| SEBI Registration Number | INH100008984 |
| Validity | 22 December 2021, Perpetual |
| Registered Address | C-4/115, Safdarjung Development Area, Hauz Khas, New Delhi 110016 |
| Correspondence Address | Same as registered address |
| Contact Person | Rakesh Bansal |
| Email Name | rakesh1973 |
What the INH Prefix Permits
The INH prefix marks a Research Analyst.
It permits publishing research and issuing recommendations to a subscriber base.
It does not permit personalised advice built around an individual client’s income, goals or holdings, trade execution, or portfolio management, all of which sit under a separate Investment Adviser licence instead.
One Bio Describes Dr. Bansal as Something His Registration Does Not Cover
A third-party contact listing for Dr. Bansal describes him as operating as a SEBI Registered Investment Advisor, offering financial planning across mutual funds, equities, fixed income, real estate and precious metals, and names a specific three-month educational program under that description.
His actual SEBI registration, INH100008984, is a Research Analyst registration, not an Investment Adviser one.
These are different licences with different permitted activities, and nothing in the material reviewed for this page shows a separate INA registration held alongside it.
This may simply be a third-party bio using the terms loosely rather than an official claim made by the firm itself.
It is still worth confirming directly which specific registration covers any personalised advisory or financial planning service you are offered, since the Research Analyst registration on record does not extend that far on its own.
Rakesh Bansal Ventures Pricing and the ₹1,51,000 SEBI Fee Cap
This is where the six-plan structure matters more than any single price tag does.
A Research Analyst may charge a maximum of ₹1,51,000 per annum per family, excluding statutory charges, for individual and HUF clients who are not accredited investors.
The Published Starting Prices, Annualised
| Plan | Coverage | Starting Price | Annualised |
|---|---|---|---|
| Index Ka Boss | Nifty and Nifty Midcap Select signals | ₹1,499/quarter | ₹5,996 |
| Alpha360 Momentum Smallcase | Multi-sector momentum portfolio | ₹4,500/quarter | ₹18,000 |
| Options Ka Ustaad | Nifty, Bank Nifty, MIDCPNIFTY options | ₹1,999/month | ₹23,988 |
| Delivery Dhamaka | Short and long term stock ideas | ₹3,800/month | ₹45,600 |
| Futures Ka Boss | Positional futures, Nifty 50 stocks | ₹5,000/month | ₹60,000 |
| Commodity Ka Sikandar | Gold, Silver, Crude Oil, Copper, Zinc, Aluminium | ₹4,199/month | ₹50,388 |
No Single Plan Breaches the Ceiling, and That Is Worth Saying Plainly
Every plan’s starting price, annualised on its own, sits well under ₹1,51,000.
Taken one at a time, this pricing structure is compliant, and it deserves credit as such rather than being treated with suspicion it has not earned.
Combining Plans Is Where the Arithmetic Changes
These six products cover genuinely different market segments: index signals, momentum portfolios, options, delivery stocks, futures and commodities, which is exactly the kind of range that encourages a client to diversify across more than one at once rather than pick a single plan and stop there.
Add every plan’s starting price together for a full year, and the total comes to ₹2,03,972, already ₹52,972 over the ceiling before accounting for the fact that these are described as starting prices, meaning the real cost of some plans may run higher still.
A client does not need to hold all six to cross the limit. Futures Ka Boss and Commodity Ka Sikandar together already come to ₹1,10,388 a year, and adding any third plan beyond that pushes the combined total past ₹1,51,000 for most pairings.
Since the ceiling applies per client family across every research service from the same analyst combined, holding more than two or three of these plans at once is enough to breach it even though each one looks modest in isolation.
If you subscribe to more than one Rakesh Bansal Ventures plan, add up your actual annual total across all of them before assuming you are within the limit, since no individual price tag on this page will tell you that on its own.
One protection applies regardless of how many plans you hold.
On early termination, a client is entitled to a proportionate refund for the unexpired period, and a Research Analyst may not retain a breakage fee.
Why Does Payment Redirect to Exly or Smallcase Instead of the Firm’s Own Site?
Several of the six plans do not process payment directly on iamrakeshbansal.com.
Clicking to subscribe instead redirects to third-party platforms, including Exly for Futures Ka Boss and Smallcase for the Alpha360 Momentum product, each handling the transaction on its own separate page.
Which platform a given plan redirects to is not consistent across the product range, and the subscription pages themselves do not clearly explain who is actually collecting the payment, under what terms, or how that third-party arrangement relates to your relationship with the registered Research Analyst before you reach the checkout screen.
This is not evidence of anything improper. Using established payment processors and platforms like Exly or Smallcase is common practice across this sector.
It does mean a prospective subscriber cannot tell from the pricing page alone which entity is actually processing a given payment, and it is worth confirming that detail, along with the refund process specific to that platform, before you pay.
One claim on the Exly checkout page for Futures Ka Boss is worth noting on its own.
It states that a detailed track record “can be seen anytime on our official WhatsApp number,” rather than publishing that record directly where a prospective subscriber is already deciding whether to pay.
A track record offered only on request, at the point of checkout, is harder to verify before you commit than one published alongside the price itself.
What If You Have Already Paid Across Multiple Plans or Through a Third Party Platform?
If your combined annual cost across two or more plans has already crossed ₹1,51,000, or a payment made through Exly or Smallcase did not go the way you expected, that is a documented, checkable problem rather than a dispute about whether the research itself was any good.
Start with your own payment records.
Add up what you have actually paid across every plan in a single financial year, and separately gather the transaction reference from whichever third-party platform processed each payment.
Write to the firm at the RA’s registered email ID with both, and ask directly which entity received each payment and under what terms.
If that does not resolve things, the matter can move beyond the firm itself.
File a fee cap complaint on the SEBI SCORES complaint portal, citing your combined annual total against the ₹1,51,000 ceiling directly.
Where that does not resolve it, the SMART ODR portal moves the matter into structured conciliation.
Beyond that, arbitration in stock exchange proceedings ends in a binding, enforceable award rather than a response you have to simply accept.
Our full guide on complaint against SEBI registered research analyst walks through how to sequence a case like this from the first email onward.
Unsure if combining plans has crossed the fee cap?
We total your invoices across every plan, confirm which platform actually processed each payment, and put the combined figure on record in a form the analyst has to respond to. Register with us for a free read on your situation.
Disclaimer
This page is based on Rakesh Bansal Ventures’ own published material, its third-party payment platform pages, and the SEBI intermediary register, current as of September 2026, and alleges no wrongdoing since no SEBI order stands against the firm.
Registration details, pricing, and website content can change, so verify everything at source before acting. Treat this page as research, not legal or investment advice.
Conclusion
Rakesh Bansal Ventures holds a genuine SEBI Research Analyst registration, INH100008984, and its six plans are individually priced well within the SEBI fee ceiling.
The risk here is structural rather than a single overpriced plan.
A product range built around six distinct market segments naturally encourages combining more than one, and doing so pushes the combined annual cost past ₹1,51,000 faster than any individual price tag suggests.
A third-party bio describing Dr. Bansal as an Investment Advisor, a licence separate from the one he actually holds, is worth a direct question before relying on any personalised advice offered under that framing.
Before subscribing to more than one plan, add up the real annual total across everything you are considering, not just the plan in front of you.
Report. Recover. Stay Fraud Free.
Frequently Asked Questions
Yes. It is registered to Rakesh Bansal Ventures, held by Dr. Rakesh Bansal, and is perpetual since December 2021. Confirm it directly on the SEBI register rather than relying on the website alone.
No. Every plan's starting price stays well under ₹1,51,000 even annualised on its own. The risk arises when a client subscribes to more than one plan at the same time.
It depends on which plans, but combining even two of the higher priced options, such as Futures Ka Boss and Commodity Ka Sikandar, already exceeds ₹1,10,000 a year, leaving little room before a third plan pushes the total over the ceiling.
His confirmed SEBI registration, INH100008984, is a Research Analyst registration. A third party bio separately describes him as an Investment Advisor, a different licence, so confirm directly which registration covers any personalised advice you are offered.
That is covered in full on our dedicated Rakesh Bansal Ventures Reviews page, which includes the firm's complaint disclosure and independent app store reviews rather than being repeated here.
Add us as a preferred source on Google »
